Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P05 - Early Stage/Localized Disease - Radiotherapy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P05.04 - Association of Lymphopenia and Disease Progression in Unresectable NSCLC Treated with Definitive Chemoradiation and Immunotherapy

      00:00 - 00:00  |  Presenter: Cole Friedes

      • Abstract

      Loading...

  • +

    P21 - Locoregional and Oligometastatic Disease - Treatment of Locally Advanced NSCLC

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • +

      P21.04 - Comparing Outcomes for Patients Receiving Chemoradiation Followed by Surgery vs. Immune Checkpoint Inhibitors in Non Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Turja Chakrabarti

      • Abstract

      Loading...

  • +

    IS10 - Industry Symposium Sponsored by Bristol Myers Squibb: Thoracic Cancers, New Developments with IO

    • 13:00 - 14:00
    • 1/29/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS10.03 - IO in the Treatment of Metastatic NSCLC, Where Are We Now?

      13:20 - 13:35  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

    • +

      IS10.04 - Non-Metastatic and Metastatic NSCLC Q&A

      13:35 - 13:40  |  Presenter: Virginie Westeel, Julie Brahmer

      • Abstract

      No abstract available for this presentation

  • +

    ES14 - Novel Immunotherapy Strategies in NSCLC

    • 11:45 - 12:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      ES14.03 - Combining Epigenetic Therapy and Immunotherapy in NSCLC

      11:57 - 12:09  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

  • +

    IS11 - Industry Symposium Sponsored by Amgen Oncology: Advancing the Next Frontier of Innovation in Lung Cancer Therapies

    • 13:00 - 14:00
    • 1/30/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS11.04 - Emerging Novel Targets for Lung Cancer

      13:40 - 14:00  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

  • +

    MA07 - Improving Care for People with Lung Cancer: Decision Making, Survivorship, and New Challenges During COVID-19

    • 15:30 - 16:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Patient Advocacy
    • +

      MA07.05 - Survivors from Anti-PD-(L)1 Immunotherapy in NSCLC: Clinical Features, Survival Outcomes and Long-term Toxicities

      15:50 - 15:55  |  Presenter: Melinda Hsu

      • Abstract

      Loading...